Add this topic to your myFT Digest for news straight to your inbox
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
How to reboot, from silent disco-yoga in Cornwall to sound-scaping in Tuscany
New apps suggest facial exercise can turn back the clock
Pledges to invest in pandemic preparedness with facility in Kenya fall short as sales of Covid jabs decline
PM’s intervention comes after report finds ‘remarkably weak evidence’ surrounding medical interventions
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
Right ommm . . . ditch the flat white for an acoustic immersion alleged to stave off the early-afternoon slump
Decision in crucial 2024 presidential election battleground comes as Democrats hope restrictions will energise voters
Former president declines to endorse national ban but takes credit for overturning Roe vs Wade
European human rights court to set precedent for government role in causing physical and mental harm as a result of global warming
UK research highlights risk of over-diagnosis and gaps in spotting serious variants of the disease
The idea that the technology might accelerate general human capabilities remains fanciful
Growing number of countries are also considering whether to amend legislation
US healthcare company is putting cash to work from spinning off its consumer health arm
Ex-Tinder CEO Renate Nyborg thinks advanced AI can help
Research forecasts global deaths from the disease will almost double in 20 years
Outbreak kills at least one baby and is likely to worsen based on Dutch data
It aims to exploit its extraordinary cache of genetic data but changing corporate DNA is hard
WHO member states are struggling to agree the terms of the first global treaty to deal with the threat of another Covid-19
Jonathan Haidt argues that social media and gaming have disastrously rewired childhood, but haven’t we been here before?
The sixth annual ranking of companies in the region with the highest growth. Health tech businesses thrive post-pandemic even as VC funding drops. Plus: Singapore draws in start-ups; new models of corporate success in Japan; India’s EV expansion
Patients who took Sanofi’s lixisenatide experienced no worsening of motor symptoms
People (and fish) need to consume this seafood rather than wiping out stocks of the ‘big five’
Europe’s regulations have become ‘too burdensome’ and could hinder innovation, argues Michael Lohan
Widespread testing for this treatable if embarrassing condition is being hampered by lack of access to healthcare
International Edition